117. Syringomyelia
[
2 clinical trials,
4 drugs（DrugBank:
0 drug),
0 target gene / 0 target pathway ]
Searched query = "Syringomyelia"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/21/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollement | Last_Refreshed_ on | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02807142 | March 2016 | 11 June 2018 | Efficacy Assessment of the Cell Therapy Medicine NC1 in Patients With Post-traumatic Syringomyelia | Efficacy Assessment of the Cell Therapy Medicine NC1 in Patients With Post-traumatic Syringomyelia | Post-Traumatic Syringomyelia | Biological: NC 1 cell therapy | Puerta de Hierro University Hospital | Not recruiting | 18 Years | 70 Years | All | 6 | Phase 2 | ||
| 2 | EUCTR2015-002383-16-ES | 19/01/2016 | 19 February 2018 | Evaluate the efficacy of the cell therapy with NC1 medication in patients with post-traumatic syringomyelia | Evaluate the efficacy of the cell therapy with NC1 medication in patients with post-traumatic syringomyelia | Traumatic spinal cord injury, chronically established, associated with syringomyelia and neurological deficit considered irreversible.;Therapeutic area: Diseases [C] - Nervous System Diseases [C10] | Product Name: Células mesenquimales troncales adultas autólogas de medula ósea expandidas Product Code: CME-LEM4 Pharmaceutical Form: Suspension for injection INN or Proposed INN: células mesenquimales troncales adultas autólogas de médula ósea expandidas Current Sponsor code: CME-LEM4 Concentration unit: U/ml unit(s)/millilitre Concentration type: equal Concentration number: 300000000- | Fundación Investigación Biomédica Hospital Universitario Puerta de Hierro | Not Recruiting | Female: yes Male: yes | 6 | Phase 2 | Spain |